Effects of HIF-1 and HIF2 on growth and metabolism of clear-cell renal cell carcinoma 786-0 xenografts

Journal of Oncology

Volumn , Issue , 2010, Pages

  Stubbs, Marion ^d,f   Biswas, Swethajit ^a,b,c   Troy, Helen ^d,e   Leek, Russell ^b   Chung, Yuen Li ^d,e   Li, Ji Liang ^a   Raval, Raju R ^a   Turley, Helen ^b   Gatter, Kevin ^b   Pezzella, Francesco ^b   Griffiths, John R ^d,f   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f Li Ka Shing Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CASPASE 3; FREE RADICAL; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTIC ACID; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 77955370669     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/757908     Document Type: Article

References (47)

1. Semenza G. L., Targeting HIF-1 for cancer therapy Nature Reviews Cancer 2003 3 10 721 732
2. Zimmer M., Doucette D., Siddiqui N., Iliopoulos O., Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors Molecular Cancer Research 2004 2 2 89 95
3. Wang V., Davis D. A., Haque M., Huang L. E., Yarchoan R., Differential gene up-regulation by hypoxia-inducible factor-1 and hypoxia-inducible factor-2 in HEK293T cells Cancer Research 2005 65 8 3299 3306
4. Hu C.-J., Wang L.-Y., Chodosh L. A., Keith B., Simon M. C., Differential roles of hypoxia-inducible factor 1 (HIF-1 ) and HIF-2 in hypoxic gene regulation Molecular and Cellular Biology 2003 23 24 9361 9374
5. Kim J.-W., Tchernyshyov I., Semenza G. L., Dang C. V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metabolism 2006 3 3 177 185
6. Papandreou I., Cairns R. A., Fontana L., Lim A. L., Denko N. C., HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metabolism 2006 3 3 187 197
7. Semenza G. L., Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1 Biochemical Journal 2007 405 1 1 9
8. Gordan J. D., Bertout J. A., Hu C.-J., Diehl J. A., Simon M. C., HIF-2 promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity Cancer Cell 2007 11 4 335 347
9. Gordan J. D., Thompson C. B., Simon M. C., HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation Cancer Cell 2007 12 2 108 113
10. Kaelin W. G. Jr., The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer Nature Reviews Cancer 2008 8 11 865 873
11. Maranchie J. K., Vasselli J. R., Riss J., Bonifacino J. S., Linehan W. M., Klausner R. D., The contribution of VHL substrate binding and HIF1- to the phenotype of VHL loss in renal cell carcinoma Cancer Cell 2002 1 3 247 255
12. Raval R. R., Lau K. W., Tran M. G. B., Sowter H. M., Mandriota S. J., Li J.-L., Pugh C. W., Maxwell P. H., Harris A. L., Ratcliffe P. J., Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma Molecular and Cellular Biology 2005 25 13 5675 5686
13. Covello K. L., Simon M. C., Keith B., Targeted replacement of hypoxia-inducible factor-1 by a hypoxia-inducible factor-2 knock-in allele promotes tumor growth Cancer Research 2005 65 6 2277 2286
14. Kondo K., Klco J., Nakamura E., Lechpammer M., Kaelin Jr. W. G., Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Cancer Cell 2002 1 3 237 246
15. Holmquist-Mengelbier L., Fredlund E., Lfstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg A., Gradin K., Poellinger L., Phlman S., Recruitment of HIF-1 and HIF-2 to common target genes is differentially regulated in neuroblastoma: HIF-2 promotes an aggressive phenotype Cancer Cell 2006 10 5 413 423
16. Qing G., Simon M. C., Hypoxia inducible factor-2 : a critical mediator of aggressive tumor phenotypes Current Opinion in Genetics Development 2009 19 1 60 66
17. Warburg O., The Metabolism of Tumors 1930 London, UK Constable
18. Vizn P., Mazurek S., Cascante M., Robust metabolic adaptation underlying tumor progression Metabolomics 2008 4 1 1 12
19. Denko N. C., Hypoxia, HIF1 and glucose metabolism in the solid tumour Nature Reviews Cancer 2008 8 9 705 713
20. Semenza G. L., Regulation of cancer cell metabolism by hypoxia-inducible factor 1 Seminars in Cancer Biology 2009 19 1 12 16
21. Gordan J. D., Lal P., Dondeti V. R., Letrero R., Parekh K. N., Oquendo C. E., Greenberg R. A., Flaherty K. T., Rathmell W. K., Keith B., Simon M. C., Nathanson K. L., HIF- effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma Cancer Cell 2008 14 6 435 446
22. McSheehy P. M. J., Seymour M. T., Ojugo A. S. E., Rodrigues L. M., Leach M. O., Judson I. R., Griffiths J. R., A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using F 19 and P 31 magnetic resonance spectroscopy European Journal of Cancer 1997 33 14 2418 2427
23. Bergmeyer H. U., Methods of Enzymatic Analysis 1974 2nd Weinheim, Germany Verlag Chemie
24. Li J.-L., Sainson R. C. A., Shi W., Leek R., Harrington L. S., Preusser M., Biswas S., Turley H., Heikamp E., Hainfellner J. A., Harris A. L., Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo Cancer Research 2007 67 23 11244 11253
25. Fuhrman S. A., Lasky L. C., Limas C., Prognostic significance of morphologic parameters in renal cell carcinoma American Journal of Surgical Pathology 1982 6 7 655 663
26. Scheres H. M. E., De Goeij A. F. P. M., Rousch M. J. M., Hondius G. G., Willebrand D. D., Gijzen A. H., Bosman F. T., Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis Journal of Clinical Pathology 1988 41 6 623 632
27. Duan W. R., Gamer D. S., Williams S. D., Funckes-Shippy C. L., Spath I. S., Blomme E. A. G., Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts Journal of Pathology 2003 199 2 221 228
28. Sowter H. M., Ferguson M., Pym C., Watson P., Fox S. B., Han C., Harris A. L., Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade Journal of Pathology 2003 201 4 573 580
29. Fox S. B., Leek R. D., Weekes M. P., Whitehouse R. M., Gatter K. C., Harris A. L., Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis Journal of Pathology 1995 177 3 275 283
30. Madhu B., Robinson S. P., Howe F. A., Griffiths J. R., Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo H 1 MRS Journal of Magnetic Resonance Imaging 2008 28 5 1201 1208
31. Ordidge R. J., Connelly A., Lohman J. A. B., Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy Journal of Magnetic Resonance 1986 66 2 283 294
32. Azad M. B., Chen Y., Henson E. S., Cizeau J., McMillan-Ward E., Israels S. J., Gibson S. B., Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3 Autophagy 2008 4 2 195 204
33. Mellor H. R., Harris A. L., The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer Cancer and Metastasis Reviews 2007 26 3-4 553 566
34. Ojugo A. S. E., McSheehy P. M. J., McIntyre D. J. O., McCoy C., Stubbs M., Leach M. O., Judson I. R., Griffiths J. R., Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous F 19 and P 31 probes NMR in Biomedicine 1999 12 8 495 504
35. Govindarajan B., Sligh J. E., Vincent B. J., Li M., Canter J. A., Nickoloff B. J., Rodenburg R. J., Smeitink J. A., Oberley L., Zhang Y., Slingerland J., Arnold R. S., Lambeth J. D., Cohen C., Hilenski L., Griendling K., Martnez-Diez M., Cuezva J. M., Arbiser J. L., Overexpression of Akt converts radial growth melanoma to vertical growth melanoma Journal of Clinical Investigation 2007 117 3 719 729
36. Robey R. B., Hay N., Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt Oncogene 2006 25 34 4683 4696
37. Ackerstaff E., Glunde K., Bhujwalla Z. M., Choline phospholipid metabolism: a target in cancer cells? Journal of Cellular Biochemistry 2003 90 3 525 533
38. Favier J., Lapointe S., Maliba R., Sirois M. G., HIF2 reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma BMC Cancer 2007 7, article 139
39. Imamura T., Kikuchi H., Herraiz M.-T., Park D.-Y., Mizukami Y., Mino-Kenduson M., Lynch M. P., Rueda B. R., Benita Y., Xavier R. J., Chung D. C., HIF-1 and HIF-2 have divergent roles in colon cancer International Journal of Cancer 2009 124 4 763 771
40. Acker T., Diez-Juan A., Aragones J., Tjwa M., Brusselmans K., Moons L., Fukumura D., Moreno-Murciano M. P., Herbert J.-M., Burger A., Riedel J., Elvert G., Flamme I., Maxwell P. H., Collen D., Dewerchin M., Jain R. K., Plate K. H., Carmeliet P., Genetic evidence for a tumor suppressor role of HIF-2 Cancer Cell 2005 8 2 131 141
41. Plas D. R., Thompson C. B., Akt-dependent transformation: there is more to growth than just surviving Oncogene 2005 24 50 7435 7442
42. Sakamaki T., Casimiro M. C., Ju X., Quong A. A., Katiyar S., Liu M., Jiao X., Li A., Zhang X., Lu Y., Wang C., Byers S., Nicholson R., Link T., Shemluck M., Yang J., Fricke S. T., Novikoff P. M., Papanikolaou A., Arnold A., Albanese C., Pestell R., Cyclin D1 determines mitochondrial function in vivo Molecular and Cellular Biology 2006 26 14 5449 5469
43. Hervouet E., Demont J., Pecina P., Vojtskov A., Houstek J., Simonnet H., Godinot C., A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis Carcinogenesis 2005 26 3 531 539
44. Elstrom R. L., Bauer D. E., Buzzai M., Karnauskas R., Harris M. H., Plas D. R., Zhuang H., Cinalli R. M., Alavi A., Rudin C. M., Thompson C. B., Akt stimulates aerobic glycolysis in cancer cells Cancer Research 2004 64 11 3892 3899
45. Semenza G. L., Mitochondrial autophagy: life and breath of the cell Autophagy 2008 4 4 534 536
46. Nogueira V., Park Y., Chen C.-C., Xu P.-Z., Chen M.-L., Tonic I., Unterman T., Hay N., Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis Cancer Cell 2008 14 6 458 470
47. Kaelin W. G. Jr., Ratcliffe P. J., Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway Molecular Cell 2008 30 4 393 402